Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

NaV1.9 channels in muscle afferent neurons and axons.

Marler TL, Wright AB, Elmslie KL, Heier AK, Remily E, Kim-Han JS, Ramachandra R, Elmslie KS.

J Neurophysiol. 2018 Sep 1;120(3):1032-1044. doi: 10.1152/jn.00573.2017. Epub 2018 May 30.

PMID:
29847236
2.

Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.

Romero HK, Christensen SB, Di Cesare Mannelli L, Gajewiak J, Ramachandra R, Elmslie KS, Vetter DE, Ghelardini C, Iadonato SP, Mercado JL, Olivera BM, McIntosh JM.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1825-E1832. doi: 10.1073/pnas.1621433114. Epub 2017 Feb 21.

3.

EXPRESS: Voltage-dependent sodium (NaV) channels in group IV sensory afferents.

Ramachandra R, Elmslie KS.

Mol Pain. 2016 Jul 5;12. pii: 1744806916660721. doi: 10.1177/1744806916660721. Print 2016.

4.

Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.

Luo S, Zhangsun D, Harvey PJ, Kaas Q, Wu Y, Zhu X, Hu Y, Li X, Tsetlin VI, Christensen S, Romero HK, McIntyre M, Dowell C, Baxter JC, Elmslie KS, Craik DJ, McIntosh JM.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4026-35. doi: 10.1073/pnas.1503617112. Epub 2015 Jul 13.

5.

Limited efficacy of α-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron CaV current.

Wright AB, Norimatsu Y, McIntosh JM, Elmslie KS.

eNeuro. 2015 Jan-Feb;2(1). doi: 10.1523/ENEURO.0057-14.2015.

6.

Single channel measurements demonstrate the voltage dependence of permeation through N-type and L-type CaV channels.

Buraei Z, Lee HK, Elmslie KS.

Channels (Austin). 2015;9(1):50-5. doi: 10.4161/19336950.2014.991606.

7.

Voltage control of Ca²⁺ permeation through N-type calcium (Ca(V)2.2) channels.

Buraei Z, Liang H, Elmslie KS.

J Gen Physiol. 2014 Sep;144(3):207-20. doi: 10.1085/jgp.201411201. Epub 2014 Aug 11.

8.

Functional expression of α7-nicotinic acetylcholine receptors by muscle afferent neurons.

Baxter JC, Ramachandra R, Mayne DR, Elmslie KS.

J Neurophysiol. 2014 Sep 15;112(6):1549-58. doi: 10.1152/jn.00035.2014. Epub 2014 Jun 25.

9.

Identification of CaV channel types expressed in muscle afferent neurons.

Ramachandra R, Hassan B, McGrew SG, Dompor J, Farrag M, Ruiz-Velasco V, Elmslie KS.

J Neurophysiol. 2013 Oct;110(7):1535-43. doi: 10.1152/jn.00069.2013. Epub 2013 Jul 10.

10.

NaV1.8 channels are expressed in large, as well as small, diameter sensory afferent neurons.

Ramachandra R, McGrew SY, Baxter JC, Howard JR, Elmslie KS.

Channels (Austin). 2013 Jan 1;7(1):34-7. doi: 10.4161/chan.22445. Epub 2012 Oct 12.

11.

Tetrodotoxin-resistant voltage-dependent sodium channels in identified muscle afferent neurons.

Ramachandra R, McGrew SY, Baxter JC, Kiveric E, Elmslie KS.

J Neurophysiol. 2012 Oct;108(8):2230-41. doi: 10.1152/jn.00219.2012. Epub 2012 Aug 1.

12.

Dissecting a role of evolutionary-conserved but noncritical disulfide bridges in cysteine-rich peptides using ω-conotoxin GVIA and its selenocysteine analogs.

Gowd KH, Blais KD, Elmslie KS, Steiner AM, Olivera BM, Bulaj G.

Biopolymers. 2012;98(3):212-23. doi: 10.1002/bip.22047.

13.

Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.

Yarotskyy V, Gao G, Peterson BZ, Elmslie KS.

J Neurophysiol. 2012 Apr;107(7):1942-51. doi: 10.1152/jn.00993.2011. Epub 2011 Dec 28.

14.

Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.

Yarotskyy V, Elmslie KS.

J Pharmacol Exp Ther. 2012 Feb;340(2):463-72. doi: 10.1124/jpet.111.187104. Epub 2011 Nov 16.

15.

Amino acid substitutions in the FXYD motif enhance phospholemman-induced modulation of cardiac L-type calcium channels.

Guo K, Wang X, Gao G, Huang C, Elmslie KS, Peterson BZ.

Am J Physiol Cell Physiol. 2010 Nov;299(5):C1203-11. doi: 10.1152/ajpcell.00149.2010. Epub 2010 Aug 18.

16.

The intravenous anesthetic propofol inhibits human L-type calcium channels by enhancing voltage-dependent inactivation.

Fassl J, High KM, Stephenson ER, Yarotskyy V, Elmslie KS.

J Clin Pharmacol. 2011 May;51(5):719-30. doi: 10.1177/0091270010373098. Epub 2010 Jun 14.

PMID:
20547772
17.

Interference between two modulators of N-type (CaV2.2) calcium channel gating demonstrates that omega-conotoxin GVIA disrupts open state gating.

Yarotskyy V, Elmslie KS.

Biochim Biophys Acta. 2010 Sep;1798(9):1821-8. doi: 10.1016/j.bbamem.2010.05.004. Epub 2010 May 13.

18.

Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.

Ganapathi SB, Fox TE, Kester M, Elmslie KS.

Am J Physiol Cell Physiol. 2010 Jul;299(1):C74-86. doi: 10.1152/ajpcell.00462.2009. Epub 2010 Apr 7.

19.

Phospholemman modulates the gating of cardiac L-type calcium channels.

Wang X, Gao G, Guo K, Yarotskyy V, Huang C, Elmslie KS, Peterson BZ.

Biophys J. 2010 Apr 7;98(7):1149-59. doi: 10.1016/j.bpj.2009.11.032.

20.

Site-specific effects of diselenide bridges on the oxidative folding of a cystine knot peptide, omega-selenoconotoxin GVIA.

Gowd KH, Yarotskyy V, Elmslie KS, Skalicky JJ, Olivera BM, Bulaj G.

Biochemistry. 2010 Mar 30;49(12):2741-52. doi: 10.1021/bi902137c.

21.

A single amino acid change in Ca(v)1.2 channels eliminates the permeation and gating differences between Ca(2+) and Ba(2+).

Li Z, Wang X, Gao G, Qu D, Yu B, Huang C, Elmslie KS, Peterson BZ.

J Membr Biol. 2010 Feb;233(1-3):23-33. doi: 10.1007/s00232-009-9221-1. Epub 2010 Jan 23.

22.

Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation.

Yarotskyy V, Gao G, Du L, Ganapathi SB, Peterson BZ, Elmslie KS.

J Biol Chem. 2010 Jan 1;285(1):43-53. doi: 10.1074/jbc.M109.076448. Epub 2009 Nov 2.

23.

Open-state occupancy prevents gating charge relaxation of N-type (CaV2.2) calcium channels.

Yarotskyy V, Elmslie KS.

Biophys J. 2009 Nov 4;97(9):2446-55. doi: 10.1016/j.bpj.2009.08.014.

24.

State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.

Ganapathi SB, Kester M, Elmslie KS.

Am J Physiol Cell Physiol. 2009 Apr;296(4):C701-10. doi: 10.1152/ajpcell.00633.2008. Epub 2009 Feb 25.

25.

The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation.

Yarotskyy V, Gao G, Peterson BZ, Elmslie KS.

J Physiol. 2009 Feb 1;587(3):551-65. doi: 10.1113/jphysiol.2008.161737. Epub 2008 Dec 15.

26.

omega-conotoxin GVIA alters gating charge movement of N-type (CaV2.2) calcium channels.

Yarotskyy V, Elmslie KS.

J Neurophysiol. 2009 Jan;101(1):332-40. doi: 10.1152/jn.91064.2008. Epub 2008 Oct 29.

27.

The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels.

Buraei Z, Elmslie KS.

J Neurochem. 2008 May;105(4):1450-61. doi: 10.1111/j.1471-4159.2008.05248.x. Epub 2008 Jan 23.

28.
29.

Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.

Buraei Z, Schofield G, Elmslie KS.

Neuropharmacology. 2007 Mar;52(3):883-94. Epub 2006 Nov 27.

PMID:
17125805
30.

Ca2+ enhances U-type inactivation of N-type (CaV2.2) calcium current in rat sympathetic neurons.

Goo YS, Lim W, Elmslie KS.

J Neurophysiol. 2006 Sep;96(3):1075-83. Epub 2006 Jun 7.

31.

Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.

Buraei Z, Anghelescu M, Elmslie KS.

Biophys J. 2005 Sep;89(3):1681-91. Epub 2005 Jun 10.

32.

Neurotransmitter modulation of neuronal calcium channels.

Elmslie KS.

J Bioenerg Biomembr. 2003 Dec;35(6):477-89. Review.

PMID:
15000517
33.

Calcium channel blockers in the treatment of disease.

Elmslie KS.

J Neurosci Res. 2004 Mar 15;75(6):733-41. Review.

PMID:
14994334
35.
37.
38.
40.

Transmitter modulation of neuronal calcium channels.

Jones SW, Elmslie KS.

J Membr Biol. 1997 Jan 1;155(1):1-10. Review. No abstract available.

PMID:
9002420
42.
43.

Reevaluation of Ca2+ channel types and their modulation in bullfrog sympathetic neurons.

Elmslie KS, Kammermeier PJ, Jones SW.

Neuron. 1994 Jul;13(1):217-28.

PMID:
8043277
44.

Phosphorylation enhances inactivation of N-type calcium channel current in bullfrog sympathetic neurons.

Werz MA, Elmslie KS, Jones SW.

Pflugers Arch. 1993 Sep;424(5-6):538-45.

PMID:
8255738
45.

Effects of temperature on calcium current of bullfrog sympathetic neurons.

van Lunteren E, Elmslie KS, Jones SW.

J Physiol. 1993 Jul;466:81-93.

46.

Intracellular ATP and GTP are both required to preserve modulation of N-type calcium channel current by norepinephrine.

Elmslie KS, Werz MA, Overholt JL, Jones SW.

Pflugers Arch. 1993 Jun;423(5-6):472-9.

PMID:
8394568
47.
49.

Separation and modulation of calcium currents in bullfrog sympathetic neurons.

Jones SW, Elmslie KS.

Can J Physiol Pharmacol. 1992;70 Suppl:S56-63. Review.

PMID:
1338298
50.

LHRH and GTP-gamma-S modify calcium current activation in bullfrog sympathetic neurons.

Elmslie KS, Zhou W, Jones SW.

Neuron. 1990 Jul;5(1):75-80.

PMID:
2164405

Supplemental Content

Loading ...
Support Center